Literature DB >> 15105546

Interleukin-18 and glycosaminoglycan binding by a protein encoded by Variola virus.

David J Esteban1, Anthony A Nuara1, R Mark L Buller1.   

Abstract

Poxvirus interleukin (IL)-18 binding proteins (IL-18BPs) are soluble decoys that inhibit the activity of IL-18. The aim of this study was to demonstrate IL-18 binding activity of the Variola virus protein D7L. D7L effectively inhibited the biological activity of IL-18 in a bioassay. We compared the affinity and kinetics of D7L and the Ectromelia virus IL-18BP, p13, for human and murine IL-18 using surface plasmon resonance and no differences were detected, indicating that the differences in amino acid sequence did not affect binding or species specificity. Both proteins had higher affinity for murine than human IL-18. This was similar to human IL-18BP and the Molluscum contagiosum virus IL-18BP, which also demonstrated higher affinity for human IL-18. The host range of Variola virus is limited to humans and thus the affinity of D7L for IL-18 does not correlate with its host range. Furthermore, we demonstrated that D7L is capable of interacting with glycosaminoglycans (GAGs) via the C terminus, while p13 is not. Importantly, D7L interacted with both GAG and IL-18 simultaneously, indicating that the binding sites were distinct.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105546     DOI: 10.1099/vir.0.79902-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Smallpox: an ancient disease enters the modern era of virogenomics.

Authors:  Grant McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-12       Impact factor: 11.205

2.  Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit.

Authors:  Xiangzhi Meng; Michael Leman; Yan Xiang
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

3.  An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain.

Authors:  M Begoña Ruiz-Argüello; Vincent P Smith; Gabriele S V Campanella; Françoise Baleux; Fernando Arenzana-Seisdedos; Andrew D Luster; Antonio Alcami
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

4.  A synergistic role for IL-1beta and TNFalpha in monocyte-derived IFNgamma inducing activity.

Authors:  Raquel M Raices; Yashaswini Kannan; Anasuya Sarkar; Vedavathi Bellamkonda-Athmaram; Mark D Wewers
Journal:  Cytokine       Date:  2008-09-19       Impact factor: 3.861

5.  The inflammasome as a target of modulation by DNA viruses.

Authors:  Lisi Amsler; Daniel Malouli; Victor DeFilippis
Journal:  Future Virol       Date:  2013-04-01       Impact factor: 1.831

Review 6.  Evasion and interference: intracellular pathogens modulate caspase-dependent inflammatory responses.

Authors:  Mary K Stewart; Brad T Cookson
Journal:  Nat Rev Microbiol       Date:  2016-05-13       Impact factor: 60.633

7.  The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.

Authors:  Kathleen H Rubins; Lisa E Hensley; Peter B Jahrling; Adeline R Whitney; Thomas W Geisbert; John W Huggins; Art Owen; James W Leduc; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

8.  A novel role for IkappaBzeta in the regulation of IFNgamma production.

Authors:  Raquel M Raices; Yashaswini Kannan; Vedavathi Bellamkonda-Athmaram; Sudarshan Seshadri; Huating Wang; Denis C Guttridge; Mark D Wewers
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

9.  Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3.

Authors:  João M Dias; Christophe Losberger; Maud Déruaz; Christine A Power; Amanda E I Proudfoot; Jeffrey P Shaw
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

10.  The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon.

Authors:  María del Mar Fernández de Marco; Alí Alejo; Paul Hudson; Inger K Damon; Antonio Alcami
Journal:  FASEB J       Date:  2009-12-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.